HOSTED PROTOTYPE

Use synthetic data only. No prescriptions are issued or medications dispensed.

Urology

Compare Oxybutynin vs. solifenacin

Compare two antimuscarinic medicines discussed for certain overactive-bladder symptoms.

MEDICAL REVIEW REQUIREDFDA and DailyMed labeling · editorial prototype

Key takeaways

  • Both are antimuscarinic medicines, but they are distinct products with different labeling.
  • A clinician reviews symptoms, urinary retention risk, bowel and eye history, other medicines, and adverse effects.
  • An overactive-bladder symptom pattern may need evaluation before medication is appropriate.

How they compare

EDITORIAL GUIDE
TopicOxybutynin ERoxybutynin chlorideSolifenacinsolifenacin succinate
Medication familyAntimuscarinicAntimuscarinic
Common discussionSelected overactive-bladder symptomsSelected overactive-bladder symptoms
Product formExtended-release oral tabletOral tablet
AccessPrescription requiredPrescription required
DecisionRequires an individual clinician reviewRequires an individual clinician review

Primary sources

Labeling can change. Use the current FDA prescribing information and speak with a licensed clinician or pharmacist before making a treatment decision.

Oxybutynin ER labeling on DailyMed Solifenacin labeling on DailyMed